Neogen Corporation
NEOG Healthcare Medical Devices
Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.
- Revenue
- +6.50%
- EPS
- −129.4%
- Free cash flow
- +135.6%
- Total debt
- −2.31%
Quarter to August 2026, against a year earlier
Follow NEOG
Alert me
Neogen Corporation (NEOG) Book value per share
Neogen Corporation's book value per share at the end of fiscal 2026 was 9.6×, unchanged from fiscal 2025. At the end of the quarter to 31 August 2026 it was 9.6×. Over the past ten years it has ranged from 3.6× (fiscal 2015) to 16.6× (fiscal 2023); the current reading is higher than 83% of that period. Neogen Corporation ranks 36th of 149 Medical Devices companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2026 | 9.6× | 0.77% |
| FY2025 | 9.5× | (34.25%) |
| FY2024 | 14.5× | (12.48%) |
| FY2023 | 16.6× | 101.37% |
| FY2022 | 8.2× | 4.43% |
| FY2021 | 7.9× | 14.36% |
| FY2020 | 6.9× | 12.25% |
| FY2019 | 6.1× | 12.71% |
| FY2018 | 5.5× | 16.86% |
| FY2017 | 4.7× | 15.17% |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Aug 2026 | 9.6× | (0.58%) |
| May 2026 | 9.6× | (0.36%) |
| Feb 2026 | 9.7× | (0.23%) |
| Nov 2025 | 9.7× | (0.76%) |
| 43 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| UFPT UFP Technologies, Inc. compare | 62.7× |
| ITGR Integer Holdings Corporation compare | 50.7× |
| INSP Inspire Medical Systems, Inc. compare | 28.6× |
| TMDX TransMedics Group, Inc. compare | 15.9× |
| NEOG Neogen Corporation | 9.6× |
| AXGN AxoGen, Inc. compare | 9.0× |
| ALMR Alamar Biosciences, Inc. compare | 4.4× |
| ESTA Establishment Labs Holdings Inc. compare | 0.7× |
| BFLY Butterfly Network, Inc. compare | 0.7× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on NEOG
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement